Now Live The BioInsights Podcast Modernizing cell therapy manufacturing to reduce vein-to-vein times

Listen now

Curate Biosciences and City of Hope Evaluate Innovative Cell Separation for HIV CAR-T Cell Therapy Production

CARLSBAD, Calif., April 5, 2022 /PRNewswire/ — Curate Biosciences, a key enabling technology company for cell therapy manufacturing, announced the first outcome of its Technology Access Program, which is dedicated to converting research into real-world treatments and cures as rapidly as possible. City of Hope, one of the largest cancer research and treatment organizations in the United States, has evaluated the Curate® Cell Processing System for advanced cell separation and plans to integrate the platform into its workflow to manufacture investigational CAR-T cell immunotherapy.

Read the full story.